117 related articles for article (PubMed ID: 8890756)
21. The Relationship of Carotid Arterial Stiffness and Left Ventricular Concentric Hypertrophy in Hypertension.
Jaroch J; Łoboz-Grudzień K; Magda S; Florescu M; Bociąga Z; Ciobanu AO; Kruszyńska E; Dudek K; Vinereanu D
Adv Clin Exp Med; 2016; 25(2):263-72. PubMed ID: 27627559
[TBL] [Abstract][Full Text] [Related]
22. Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network).
Lønnebakken MT; Izzo R; Mancusi C; Gerdts E; Losi MA; Canciello G; Giugliano G; De Luca N; Trimarco B; de Simone G
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275070
[TBL] [Abstract][Full Text] [Related]
23. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients.
Muiesan ML; Salvetti M; Monteduro C; Bonzi B; Paini A; Viola S; Poisa P; Rizzoni D; Castellano M; Agabiti-Rosei E
Hypertension; 2004 Apr; 43(4):731-8. PubMed ID: 15007041
[TBL] [Abstract][Full Text] [Related]
24. Left ventricular hypertrophy and its regression in essential arterial hypertension. A tissue Doppler imaging study.
Di Bello V; Giorgi D; Pedrinelli R; Talini E; Palagi C; Delle Donne MG; Zucchelli G; Dell'omo G; Di Cori A; Dell'Anna R; Caravelli P; Mariani M
Am J Hypertens; 2004 Oct; 17(10):882-90. PubMed ID: 15485749
[TBL] [Abstract][Full Text] [Related]
25. [Left ventricular remodeling in arterial hypertension and its therapy].
Dúbrava J
Vnitr Lek; 1998 Jan; 44(1):50-6. PubMed ID: 9750485
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy.
Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Santucci A; Santucci C; Reboldi G; Porcellati C
Am J Cardiol; 1996 Jul; 78(2):197-202. PubMed ID: 8712142
[TBL] [Abstract][Full Text] [Related]
27. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
[TBL] [Abstract][Full Text] [Related]
28. Current Perspectives on Left Ventricular Geometry in Systemic Hypertension.
Oktay AA; Lavie CJ; Milani RV; Ventura HO; Gilliland YE; Shah S; Cash ME
Prog Cardiovasc Dis; 2016; 59(3):235-246. PubMed ID: 27614172
[TBL] [Abstract][Full Text] [Related]
29. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
[TBL] [Abstract][Full Text] [Related]
30. Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension.
Assadi F
Pediatr Cardiol; 2007; 28(1):27-33. PubMed ID: 17308944
[TBL] [Abstract][Full Text] [Related]
31. Left ventricular hypertrophy and hypertension.
Devereux RB; de Simone G; Ganau A; Koren MJ; Mensah GA; Roman MJ
Clin Exp Hypertens; 1993 Nov; 15(6):1025-32. PubMed ID: 8268870
[TBL] [Abstract][Full Text] [Related]
32. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults.
Roman MJ; Pickering TG; Schwartz JE; Pini R; Devereux RB
J Am Coll Cardiol; 1996 Sep; 28(3):751-6. PubMed ID: 8772767
[TBL] [Abstract][Full Text] [Related]
33. Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
Krauser DG; Devereux RB
Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470
[TBL] [Abstract][Full Text] [Related]
34. Left ventricular geometric patterns and QT dispersion in untreated essential hypertension.
Buğra Z; Koylan N; Vural A; Erzengin F; Umman B; Yilmaz E; Meriç M; Büyüköztürk K
Am J Hypertens; 1998 Oct; 11(10):1164-70. PubMed ID: 9799032
[TBL] [Abstract][Full Text] [Related]
35. Changes in left ventricular geometry during antihypertensive treatment.
Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
[TBL] [Abstract][Full Text] [Related]
36. Influence of Left Ventricular Hypertrophy on In-Hospital Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Vallabhajosyula S; Sundaragiri PR; Kanmanthareddy A; Ahmed AA; Mahfood Haddad T; Rayes HA; Khan AN; Buaisha HM; Pershwitz GE; McCann DA; Holmberg MJ; Morrow LE
COPD; 2016 Dec; 13(6):712-717. PubMed ID: 27379826
[TBL] [Abstract][Full Text] [Related]
37. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
[TBL] [Abstract][Full Text] [Related]
38. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy.
Dahlof B; Zanchetti A; Diez J; Nicholls MG; Yu CM; Barrios V; Aurup P; Smith RD; Johansson M;
J Hypertens; 2002 Sep; 20(9):1855-64. PubMed ID: 12195129
[TBL] [Abstract][Full Text] [Related]
39. [Regression of left ventricular hypertrophy and improvement of its diastolic function in patients with arterial hypertension under influence of antihypertensive therapy].
Borzova NV; Gorbachenkov AA
Kardiologiia; 2008; 48(6):44-50. PubMed ID: 18729836
[TBL] [Abstract][Full Text] [Related]
40. Changes in midwall systolic performance and cardiac hypertrophy reduction in hypertensive patients.
Muiesan ML; Salvetti M; Monteduro C; Rizzoni D; Corbellini C; Castellano M; Porteri E; Agabiti-Rosei E
J Hypertens; 2000 Nov; 18(11):1651-6. PubMed ID: 11081779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
